microcurrent application linked to meaningful reductions in depression symptom scores over 6 months
Microcurrent therapy produced statistically significant and clinically relevant reductions in depression symptom severity (PHQ-9 scores) in patients with fibromyalgia and depression over 6 months.
What this means for you
When depression symptom scores drop in a measurable, clinically relevant way, that reflects real shifts in how people feel day to day — mood, motivation, and mental heaviness. For anyone carrying the weight of low mood alongside physical discomfort, even a meaningful reduction in symptom burden can feel like getting some of yourself back.
The published research
Observational Study to Assesses the Efficacy and Safety of Microcurrent Therapy with a Portable Device in Patients Suffering from Chronic Back Pain, Skeletal System Pain, Fibromyalgia, Migraine or Depression
Medical Devices: Evidence and Research · 2023
This page describes a documented finding about the underlying wellness technology. It is not a marketing claim about any specific device. For information about HOCATT specifically, visit hocatt.com.